Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)

Historical Holders from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
IPSC on Nasdaq
Shares outstanding
87,511,833
Price per share
$0.9000
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
20,280,322
Holdings value
$10,103,490
% of all portfolios
0%
Share change
-2,345,667
Value change
-$1,196,888
Average buys %
+0%
Average sells %
-0%
Number of holders
53
Price from insider filings
$0.9950
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 5.4% $2,504,589 4,725,639 Point72 Asset Management, L.P. 23 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 4.7% $1,899,449 3,957,186 Venrock Healthcare Capital Partners III, L.P. 31 Dec 2024
Bain Capital Life Sciences Opportunities III, LP 4.1% $1,763,289 3,538,609 Bain Capital Life Sciences Opportunities III, LP 30 Sep 2025
Casdin Capital, LLC 3.7% $1,541,912 3,212,316 Casdin Capital, LLC 31 Mar 2025
As of 30 Sep 2025, Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) has 53 institutional shareholders filing 13F forms. They hold 20,280,322 shares of 87,511,833 outstanding shares (23%) .

Top 25 institutional shareholders own 23% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Bain Capital Life Sciences Investors, LLC 4% 3,538,609 -35% 0.12% $1,762,227
RENAISSANCE TECHNOLOGIES LLC 3% 2,586,900 +28% 0% $1,288,276
VANGUARD GROUP INC 2.4% 2,103,869 -0.29% 0% $1,047,726
DAFNA Capital Management LLC 1.9% 1,704,232 0% 0.21% $848,708
Casdin Capital, LLC 1.4% 1,228,190 0% 0.05% $611,639
Syncona Portfolio Ltd 1.4% 1,213,056 0% 2.2% $604,102
TWO SIGMA INVESTMENTS, LP 1% 911,446 +59% 0% $453,900
TANG CAPITAL MANAGEMENT LLC 1% 900,000 0% 0.02% $448,200
TWO SIGMA ADVISERS, LP 0.98% 857,600 +134% 0% $427,085
MILLENNIUM MANAGEMENT LLC 0.85% 743,781 -8.4% 0% $370,403
ACADIAN ASSET MANAGEMENT LLC 0.82% 719,808 +134% 0% $357,000
GSA CAPITAL PARTNERS LLP 0.69% 603,479 +29% 0.03% $301,000
BlackRock, Inc. 0.69% 599,656 -35% 0% $298,629
SUPERSTRING CAPITAL MANAGEMENT LP 0.53% 462,963 0% 0.23% $230,556
GEODE CAPITAL MANAGEMENT, LLC 0.51% 445,309 +17% 0% $221,845
CITADEL ADVISORS LLC 0.41% 360,825 +93% 0% $179,690
Squarepoint Ops LLC 0.27% 236,053 +483% 0% $117,554
FMR LLC 0.22% 192,139 -81% 0% $95,685
STATE STREET CORP 0.15% 127,443 0% 0% $63,467
RAYMOND JAMES FINANCIAL INC 0.1% 91,323 0% 0% $45,479
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.09% 77,853 -4.2% 0% $43,489
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.08% 67,924 -66% 0% $33,826
NORTHERN TRUST CORP 0.08% 67,000 0% 0% $33,366
GOLDMAN SACHS GROUP INC 0.07% 60,682 -78% 0% $30,220
PRUDENTIAL FINANCIAL INC 0.07% 59,800 +32% 0% $29,780

Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 77,797 $70,017 -$50 $0.9000 1
2025 Q3 20,280,322 $10,103,490 -$1,196,888 $0.4980 53
2025 Q2 22,628,192 $12,642,486 -$3,582,152 $0.5587 64
2025 Q1 29,565,044 $14,071,693 -$4,277,610 $0.4760 69
2024 Q4 36,396,154 $36,760,956 -$7,767,865 $1.01 69
2024 Q3 39,649,193 $67,797,998 -$1,211,278 $1.71 66
2024 Q2 40,117,934 $102,301,835 +$40,961,767 $2.55 59
2024 Q1 23,113,173 $96,604,731 +$23,118,069 $4.18 66
2023 Q4 10,028 $33,293 +$33,293 $3.32 1
2023 Q3 18,056,825 $36,111,405 -$2,779,520 $2.00 52
2023 Q2 19,289,848 $60,956,595 -$2,351,631 $3.16 61
2023 Q1 20,015,566 $69,451,358 -$4,614,216 $3.47 61
2022 Q4 20,892,997 $107,176,950 -$3,631,225 $5.13 65
2022 Q3 21,097,881 $208,659,435 -$4,939,947 $9.89 53
2022 Q2 21,756,602 $182,751,181 -$3,242,101 $8.40 50
2022 Q1 21,768,242 $274,031,136 +$12,299,864 $12.59 49
2021 Q4 20,691,201 $328,121,000 +$22,766,649 $15.86 49
2021 Q3 11,638,174 $292,819,288 -$16,211,134 $25.16 47
2021 Q2 16,881,896 $490,834,435 +$490,834,327 $29.34 35